Development of dendritic cells and their use in tumor therapy

Clinical Immunology

Volumn 92, Issue 2, 1999, Pages 119-127

  Björck, Pia ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; Development; Tumor

Indexed keywords

ADOPTIVE TRANSFER; ANTIGEN PRESENTATION; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DENDRITIC CELL; GENE CONTROL; HEMATOPOIETIC STEM CELL; HUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0345426361     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4748     Document Type: Review

References (73)

1. Steinman R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271-296.
2. Salomon B., Cohen J. L., Masurier C., Klatzmann D. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J. Immunol. 160:1998;708-717.
3. Scott E., Simon M., Anastasi J., Singh H. Requirement of transcription factor PU. Science. 265:1994;1573-1577.
4. Mucenski M., McLain K., Kier A., Swerdlow S., Schreiner C., Miller T., Pietryga D., Scott W., Potter S. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 65:1991;677-689.
5. Wu L., Nichogiannopoulou A., Shortman K., Georgopoulos K. Cell-autonomous defects in dendritic cell population of Ikaros mutant mice point to a developmental relationship with the lymhpoid lineage. Immunity. 7:1997;483-492.
6. Borkowski T. A., Letterio J. J., Farr A. G., Udey M. C. A role for endogenous transforming growth factor β1 in Langerhans cell biology: The skin of transforming growth factor β1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184:1996;2417-2422.
7. Carrasco D., Ryseck R.-P., Bravo R. Expression of relB transcripts during lymphoid organ development: Specific expression in dendritic antigen-presenting cells. Development. 118:1993;1221-1231.
8. Burkly L., Hession C., Ogata L., Reilly C., Marconi L. A., Olson D., Tizard R., Cate R., Lo D. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 373:1995;531-536.
9. Weih F., Carrasco D., Durham S. K., Barton D. S., Rizzo C. A., Ryseck R.-P., Lira S. A., Bravo R. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of relB, a member of the NF-kB/Rel family. Cell. 80:1995;331-340.
10. Wu L., D'Amico A., Winkel K. D., Suter M., Lo D., Shortman K. RelB is essential for the development of myeloid-related CD8α- dendritic cells but not of lymphoid-related CD8α+ dendritic cells. Immunity. 9:1998;839-847.
11. Santiago-Schwarz F., Belilos E., Dimond B., Carsons S. E. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrohpages. J. Leukocyte Biol. 52:1992;274-281.
12. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258-261.
13. Young J. W., Szabolcs P., Moore M. A. S. Identification of dendritic cell colony-forming units among normal CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α J. Exp. Med. 182:1995;1111-1120.
14. Caux C., Massacrier C., Vanbervliet B., Dubois B., van Kooten C., Durand I., Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1994;1263-1272.
15. Galy A., Travis M., Cen D., Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity. 3:1995;459-473.
16. Marquez C., Trigueros C., Franco J. M., Ramiro A. R., Carrasco Y. R., Lopez-Botet M., Toribio M. L. Identification of a common developmental pathway for thymic natural killer cells and dendritic cells. Blood. 91:1998;2760-2771.
17. Plum J., de Smedt M., Verhasselt B., Offner F., Kerre T., Vanhecke D., Leclercq G., Vandekerckhove B. In vitro intrathymic differentiation kinetics of human fetal liver CD34+CD38- progenitors reveals a phenotypically defined dendritic/T-NK precursor split. J. Immunol. 162:1999;60-68.
18. Oehler L., Majdic O., Pickl W. F., Stöckl J., Riedl E., Drach J., Rappersberger K., Geissler K., Knapp W. Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. J. Exp. Med. 187:1998;1019-1028.
19. Palucka K. A., Taquet N., Sanchez-Chapuis F., Gluckman J. C. Lipopolysaccharide can block the potential of monocytes to differentiate into dendritic cells. J. Leukocyte Biol. 65:1999;232-240.
20. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R. M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1992;1693-1702.
21. Welte T., Koch F., Schuler G., Lechner J., Doppler W., Heufler C. Granulocyte-macrophage colony-stimulating factor induces a unique set of STAT factors in murine dendritic cells. Eur. J. Immunol. 27:1997;2737-2740.
22. Caux C., Vanbervliet B., Massacrier C., Durand I., Banchereau J. Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells. Blood. 87:1996;2376-2385.
23. Vremec D., Lieschke G. J., Dunn A. R., Robb L., Metcalf D., Shortman K. The influence of granulocyte/macrohpage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 27:1997;40-44.
24. Nicola N. A., Robb L., Metcalf D., Cary D., Drinkwater C. C., Begley C. G. Functional inactivation in mice of the gene for the interleukin-3 (IL-3)-specific receptor β-chain: Implications for IL-3 function and the mechanism of receptor transmodulation in hematopoietic cells. Blood. 87:1996;2665-2574.
25. Ardavin C., Wu L., Li C.-L., Shortman K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature. 362:1993;761-763.
26. Wu L., Li C.-L., Shortman K. Thymic dendritic cell precursors: Relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny. J. Exp. Med. 184:1996;903-911.
27. Saunders D., Lucas K., Ismaili J., Wu L., Maraskovsky E., Dunn A., Shortman K. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrohpage colony-stimulating factor. J. Exp. Med. 184:1996;2185-2196.
28. Rolink A., ten Boekel E., Melchers F., Fearon D. T., Krop I., Andersson J. A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J. Exp. Med. 183:1996;187-194.
29. Hardy R. R., Carmack C. E., Shinton S. A., Kemp J. D., Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1991;1213-1225.
30. Björck P., Kincade P. W. CD19+ pro-B-cells can give rise to dendritic cells in vitro. J. Immunol. 161:1998;5795-5799.
31. Cumano A., Paige C. J., Iscove N. N., Brady G. Bipotential presursors of B cells and macrophages in murine fetal liver. Nature. 256:1992;612-615.
32. Borrello M. A., Phipps R. P. The B/macrophage cell: An elusive link between CD5+ B lymhpocytes and macrophages. Immunol. Today. 17:1996;471-475.
33. Kondo M., Weissman I. L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 91:1997;661-672.
34. Flores-Romo L., Björck P., Duvert V., van Kooten C., Sealand S., Banchereau J. CD40 ligation on human CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J. Exp. Med. 185:1997;341-349.
35. Süss G., Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand induced apoptosis. J. Exp. Med. 183:1996;1789-1796.
36. Vremec D., Shortman K. Dendritic cell subtypes in mouse lymphoid organs: Cross-correlation of surface markers, changes on incubation and differences between thymus, spleen and lymph nodes. J. Immunol. 159:1997;565-573.
37. Lyman S. D., James L., van den Bos T., de Vries P., Brasel K., Gliniak B., Hollingsworth L. T., Picha K. S., McKenna H. J., Splett R. R., Fletcher F. A., Maraskowsky E., Farrah T., Foxworthe D., Williams D. E., Beckmann M. P. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell. 75:1993;1157-1167.
38. Lyman S. D., James L., Brasel K., de Vries P., Escobar S. S., Downey H., Splett R. R., Beckmann M. P., McKenna H. J. Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood. 83:1994;2795-2801.
39. Maraskovsky E., Brasel K., Teepe M., Roux E. R., Lyman S. D., Shortman K., McKenna H. J. Dramatic increase in the number of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1996;1953-1962.
40. Pulendran B., Lingappa J., Kennedy M. K., Smith J., Teepe M., Rudensky A., Maliszewski C. R., Maraskovsky E. Developmental pathways of dendritic cells in vivo. Distinct function, phenotype, and localization of dendritic cell subsets in Flt3 ligand-treated mice. J. Immunol. 159:1997;2222-2231.
41. Lynch D. H., Andreasen A., Maraskovsky E., Whitmore J., Miller R. E., Schuh J. C. L. Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nature Med. 3:1997;625-631.
42. Nestle F. O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D. Vaccination of melanoma pateints with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4:1998;328-332.
43. Lu L., Bonham A., Chambers F. G., Watkins S. C., Hoffman R. A., Simmons R. L., Thomson A. W. Induction of nitric oxide synthase in mouse dendritic cells by IFN-γ, endotoxin, and interaction with allogeneic T cells. J. Immunol. 157:1886;3577-3586.
44. Buelens C., Verhasselt V., Groote D. d., Thielemans K., Goldman M., Willems F. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony stimulating factor. Eur. J. Immunol. 27:1997;756-762.
45. de Smedt T., van Mechelen M., Becker G. D., Urbain J., Leo O., Moser M. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27:1997;1229-1235.
46. Gabrilovich D. I., Chen H. L., Girgis K. R., Cunningham H. T., Meny G. M., Nadaf S., Kavanaugh D., Carbone D. P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature. Med. 2:1996;1096-1103.
47. Mayordomo J. I., Zorina T., Storkus W. J., Zitvogel L., Celluzzi C., Falo L. D., Melief C. J., Ilstad S. T., Kast W. M., Deleo A. B., Lotze M. T. Bone marrow-derived dendritic cells pulsed with synthetic peptides elicit protective and therapeutic antitumor immunity. Nat. Med. 1:1995;1297-1302.
48. Mayordomo J. I., Loftus D. J., Sakamoto H., de Cesare C. M., Appasamy P. M., Lotze M. T., Storkus W. J., Appella E., DeLeo A. B. Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J. Exp. Med. 183:1996;1357-1365.
49. Zitvogel L., Mayordomo J. I., Tjandrawan T., DeLeo A. B., Clarke M. R., Lotze M. T., Storkus W. J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation and T helper cell 1-associated cytokines. J. Exp. Med. 183:1996;87-97.
50. Ashley D. M., Faiola B., Nair S., Hale L. P., Bigner D. D., Gilboa E. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J. Exp. Med. 186:1997;1177-1182.
51. Boczkowski D., Nair S. M., Snyder D., Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184:1996;465-472.
52. Hart I., Colaco C. Fusion induces tumor rejection. Nature. 388:1997;626-627.
53. Gong J., Chen D., Kashiwaba M., Kufe D. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat. Med. 3:1997;558-561.
54. Celluzzi C., Falo L. D. Jr. Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J. Immunol. 160:1998;3081-3085.
55. Albert M. L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:1998;86-89.
56. Albert M. L., Pearce S. F. A., Francisco L. M., Sauter B., Roy P., Silverstein R. L., Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1998;1359-1368.
57. Lanzavecchia A. Mechanisms of antigen uptake for presentation. Curr. Opin. Immunol. 8:1996;348-354.
58. Brossart P., Bevan M. J. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: Pathway of presentation and regulation by cytokines. Blood. 90:1997;1594-1599.
59. Corr M., Tighe H., Lee D., Dudler J., Trieu M., Brinson D. C., Carson D. A. Costimulation provided by DNA immunization enhances antitumor immunity. J. Immunol. 159:1997;4999-5004.
60. Nicola M. D., Siena S., Bregni M., Longoni P., Magni M., Milanesi M., Matteucci P., Mortarini R., Anichini A., Parmiani G., Drexler I., Erfle V., Sutter G., Gianni A. M. Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors. Cancer Gene Ther. 5:1998;350-356.
61. Kim C. J., Cormier J., Roden M., Gritz L., Mazzara G. P., Fetsch P., Hijazi Y., Lee K. H., Rosenberg S. A., Marincola F. M. Use of recombinant poxviruses to stimulate anti-melanoma T cell reactivity. Ann. Surg. Oncol. 5:1998;64-76.
62. Brossart P., Goldrath A. W., Butz E. A., Martin S., Bevan M. J. Virus-mediated delivery of antigeic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158:1997;3270-3276.
63. Reeves M. E., Royal R. E., Lam J. S., Rosenberg S. A., Hwu P. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 56:1996;5672-5677.
64. Specht J. M., Wang G., Do M. T., Lam J. S., Royal R. E., Reeves M. E., Rosenberg S. A., Hwu P. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med. 186:1997;1213-1221.
65. Movassagh M., Baillou C., Cosset F. L., Klatzmann D., Guigon M., Lemoine F. M. High level of retrovirus-mediated gene transfer into dendritic cells derived from cord blood and mobilized peripheral blood CD34+ cells. Hum. Gene Therapy. 10:1999;175-187.
66. Chen K., Braun S., Lyman S., Fan Y., Traycoff C. M., Wiebke E. A., Gaddy J., Sledge G., Broxmeyer H. E., Cornetta K. Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. Cancer Res. 57:1997;3511-3516.
67. Condon C., Watkins S. C., Celluzzi C. M., Thompson K., Falo L. D. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1996;1122-1126.
68. Tüting T., Wilson C. C., Martin D. M., Kasamon Y. L., Rowles J., Ma D. I., Slingluff C. L., Wagner S. N., van den Bruggen P., Baar J., Lotze M. T., Storkus W. J. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: Enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-α J. Immunol. 160:1998;1139-1147.
69. Grohmann U., Bianchi R., Ayroldi E., Belladonna M. L., Surace D., Fioretti M. C., Puccetti P. A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state. J. Immunol. 158:1997;3593-3602.
70. Grohmann U., Belladonna M. L., Bianchi R., Orabona C., Ayroldi E., Fioretti M. C., Puccetti P. IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production. Immunity. 9:1998;315-323.
71. Corr M., Lee D. J., Carson D. A., Tighe H. Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J. Exp. Med. 184:1996;1555-1560.
72. Barratt-Boyes S. M., Watkins S. C., Finn O. J. In vivo migration of dendritic cells differentiated in vitro. J. Immunol. 158:1997;4543-4547.
73. Labeur M. S., Roters B., Pers B., Mehling A., Luger T. A., Schwarz T., Grabbe S. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 162:1999;168-175.